Sedation for terminally ill patients with cancer with uncontrollable physical distress.
about
Palliative pharmacological sedation for terminally ill adultsHaloperidol for the treatment of nausea and vomiting in palliative care patientsHaloperidol for the treatment of nausea and vomiting in palliative care patientsThe perspectives of clinical staff and bereaved informal care-givers on the use of continuous sedation until death for cancer patients: The study protocol of the UNBIASED study.Continuous deep sedation for patients nearing death in the Netherlands: descriptive studyThe Attitudes of Indian Palliative-care Nurses and Physicians to Pain Control and Palliative Sedation.Palliative sedation for terminally ill cancer patients in a tertiary cancer center in Shanghai, China.Addressing Palliative Sedation during Expert Consultation: A Descriptive Analysis of the Practice of Dutch Palliative Care Consultation Teams.Sedation at the end of life - a nation-wide study in palliative care units in Austria.Palliative sedation in a southern Appalachian community.The ethics of palliative sedation as a therapy of last resort.Palliative Sedation in Advanced Cancer Patients: Does it Shorten Survival Time? - A Systematic ReviewDistancing sedation in end-of-life care from physician-assisted suicide and euthanasia.The use of observational scales to monitor symptom control and depth of sedation in patients requiring palliative sedation: a systematic review.To explore the relationship between the use of midazolam and cessation of oral intake in the terminal phase of hospice inpatients: A retrospective case note review: Does midazolam affect oral intake in the dying?A Review of Agents for Palliative Sedation/Continuous Deep Sedation: Pharmacology and Practical Applications.The practice of continuous palliative sedation in elderly patients: a nationwide explorative study among Dutch nursing home physicians.The use of opioids in the last week of life in an acute palliative care unit.Ethical dilemmas faced by hospice nurses when administering palliative sedation to patients with terminal cancer.Patient and/or family controlled palliative sedation with midazolam for intractable symptom control: a case series.At-home palliative sedation for end-of-life cancer patients.Effectiveness of multidisciplinary team conference on decision-making surrounding the application of continuous deep sedation for terminally ill cancer patients.Clinical changes in terminally ill cancer patients and death within 48 h: when should we refer patients to a separate room?Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center.Attitudes Regarding Palliative Sedation and Death Hastening Among Swiss Physicians: A Contextually Sensitive Approach.How defining clinical practices may influence their evaluation: the case of continuous sedation at the end of life.Palliative sedation therapy does not hasten death: results from a prospective multicenter studyFlemish palliative-care nurses' attitudes to palliative sedation: a quantitative studyESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation
P2860
Q24186758-7BF1C946-B165-4A22-93C0-D7472F0742EBQ24188008-7EA58069-5AAD-4983-83B5-FC27AB041D14Q24241412-857B7C7A-478E-437F-9A75-000D29FA4C22Q30498643-825BFCA7-1F03-4A86-9203-F23FC7B72B93Q34762108-CA5271DF-EC2C-4381-BDE6-FEA0576C8AECQ34994159-09C9B90C-D62F-450C-9FE5-FF38AB3B82F5Q35216505-0187EB53-6D14-4959-9523-766DAA0FD65BQ35753648-4CDF38FF-27F4-44DF-A023-0FF7E534FC9DQ36018135-0429CEB5-F71E-4396-B6F2-5EB12FE34E10Q36632742-FF7E7A24-92BD-418F-A42F-2CE4B2833B95Q36702546-FC23E11B-0D34-43A2-9D6F-C8AA80924577Q36924213-FAF0E1AE-4A3C-48A9-AE58-FFF493D4996EQ36925369-C2C8160A-7BD1-4F86-B47A-62A1FED6E44BQ37951880-54A2C3B5-ECF1-4D8B-B388-5C7614413CE0Q38849707-511170DC-691A-40A9-9C52-58D5624B1D05Q39175922-9D7F087C-4DCA-4B67-9693-6678B0594D46Q39280860-BB9B0FB9-BB1E-4C6B-A457-A25ECB392328Q39286554-63093F93-469B-4A14-8DE5-0D8C130ADF28Q39669518-6FC15960-9440-4B06-8AF4-E5467022A09DQ41780903-3A2B1636-5793-416B-8306-BAAA89DEACF0Q43172767-93708916-D38E-4249-8550-70B0AA53093EQ44904990-363C0FBB-40A2-41A3-A18E-2E7E77452EB2Q45144220-C73B537A-4498-4477-83B0-9B7CCEEB26FFQ47169337-B37CF7C3-7A13-45F5-87AD-8F57D2151324Q48079650-509232A8-4C4E-4D9D-9177-6D739ED57D81Q48893561-D8ECF33D-964F-4523-B81D-5D2E0668169BQ56390381-56D1E2DB-04D6-4D8E-95F0-010E75E13CBEQ57105174-CE4DB374-A4C4-4182-9C0C-02FA21369326Q59273862-6C27A922-302B-49F1-A32C-7AE8A0B39774
P2860
Sedation for terminally ill patients with cancer with uncontrollable physical distress.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Sedation for terminally ill patients with cancer with uncontrollable physical distress.
@en
Sedation for terminally ill patients with cancer with uncontrollable physical distress.
@nl
type
label
Sedation for terminally ill patients with cancer with uncontrollable physical distress.
@en
Sedation for terminally ill patients with cancer with uncontrollable physical distress.
@nl
prefLabel
Sedation for terminally ill patients with cancer with uncontrollable physical distress.
@en
Sedation for terminally ill patients with cancer with uncontrollable physical distress.
@nl
P2093
P356
P1476
Sedation for terminally ill patients with cancer with uncontrollable physical distress.
@en
P2093
Hiroshi Ueoka
Hiroyasu Takeyama
Hiroyuki Kohara
Tatsuya Morita
Tomoyuki Murakami
P356
10.1089/JPM.2005.8.20
P577
2005-02-01T00:00:00Z